Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
UBS
Accenture
Harvard Business School
QuintilesIMS
Chinese Patent Office
Mallinckrodt
Merck
Farmers Insurance

Generated: October 22, 2018

DrugPatentWatch Database Preview

RILUTEK Drug Profile

« Back to Dashboard

Which patents cover Rilutek, and when can generic versions of Rilutek launch?

Rilutek is a drug marketed by Covis Pharma Bv and is included in one NDA.

The generic ingredient in RILUTEK is riluzole. There are nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the riluzole profile page.

Drug patent expirations by year for RILUTEK
Pharmacology for RILUTEK
Ingredient-typeBenzothiazoles
Drug ClassBenzothiazole
Medical Subject Heading (MeSH) Categories for RILUTEK
Synonyms for RILUTEK
1744-22-5
2-Amino-6-(Trifluoromethoxy) Benzothiazole
2-amino-6-(trifluoromethoxy)-1,3-benzothiazole
2-Amino-6-(trifluoromethoxy)-benzothiazole
2-amino-6-(trifluoromethoxy)benzo[d]thiazole
2-Amino-6-(trifluoromethoxy)benzothiazole
2-amino-6-(trifluoromethoxyl)benzothiazole
2-Amino-6-trifluoro- methoxybenzothiazole
2-Amino-6-trifluoro-methoxybenzothiazole
2-amino-6-trifluoromethoxy-benzothiazole
2-amino-6-trifluoromethoxybenzothiazole
2-Benzothiazolamine, 6-(trifluoromethoxy)-
2-Benzothiazolamine,6-(trifluoromethoxy)-
4CA-1092
6-(trifluoromethoxy)-1,3-benzothiazol-2-amine
6-(Trifluoromethoxy)-2-amino-benzothiazole
6-(trifluoromethoxy)-2-aminobenzothiazole
6-(trifluoromethoxy)benzo[d]thiazol-2-amine
6-(trifluoromethoxy)benzothiazol-2-amine
6-(trifluoromethoxy)benzothiazole-2-ylamine
6-trifluoromethoxy-1,3-benzothiazol-2-ylamine
6-trifluoromethoxy-2-amino-benzothiazole
6-Trifluoromethoxy-benzothiazol-2-ylamine
6-trifluoromethoxybenzo[d]thiazol-2-amine
6-Trifluoromethoxybenzothiazol-2-ylamine
6-trifluoromethoxybenzothiazole-2-yl-amine
744R225
7LJ087RS6F
A-5766
A13951
AB0012884
ABP000632
AC-730
AC1L1JJL
AC1Q530H
ACMC-209e89
AJ-08278
AK-59567
AKOS000265071
ALBB-006046
Amino-2 trifluoromethoxy-6 benzothiazole
Amino-2 trifluoromethoxy-6 benzothiazole [French]
AN-6550
ANW-22711
BB_SC-4839
BBL013272
BC219019
BDBM30705
BENZOTHIAZOLE, 2-AMINO-6-TRIFLUOROMETHOXY-
BF-37
BIDD:GT0055
Bio1_000416
Bio1_000905
Bio1_001394
Biomol-NT_000245
BPBio1_000037
BPBio1_000837
BRD-K21283037-001-02-5
BRD-K21283037-003-03-9
BSPBio_000033
C07937
C8H5F3N2OS
CAS-1744-22-5
CCG-39528
CHEBI:8863
CHEMBL744
cid_5070
CJ-00110
CS-2156
CTK4D4982
D00775
D0H0KB
DB-030335
DB00740
DSSTox_CID_25192
DSSTox_GSID_45192
DSSTox_RID_80739
DTXSID3045192
EN300-23782
EU-0101064
F3282-0020
FT-0082997
FT-0611194
FTALBRSUTCGOEG-UHFFFAOYSA-N
GTPL2326
HE023242
HE251158
HMS1773G08
HMS2089O19
HMS2094G07
HMS2233E14
HMS3263E10
HMS3371A09
HMS3657E13
HY-B0211
I01-2084
J10184
J10441
KB-20157
KS-00000W6R
KS-5231
Lopac-R-116
Lopac0_001064
LP01064
LS-40688
MCULE-9362288181
MFCD00210213
MLS000069369
MolPort-000-151-262
NCGC00015882-01
NCGC00015882-02
NCGC00015882-03
NCGC00015882-04
NCGC00015882-05
NCGC00015882-06
NCGC00015882-07
NCGC00015882-08
NCGC00015882-09
NCGC00015882-10
NCGC00015882-11
NCGC00015882-12
NCGC00015882-13
NCGC00015882-15
NCGC00023141-02
NCGC00023141-04
NCGC00023141-05
NCGC00023141-06
NCGC00261749-01
NSC-753433
NSC-759823
NSC753433
NSC759823
Opera_ID_548
Pharmakon1600-01505348
PK-26124
PK-26124, RP-54274, Rilutek, Riluzole
Prestwick-03A08
Prestwick0_000167
Prestwick1_000167
Prestwick2_000167
Prestwick3_000167
PubChem14501
R-116
Rilutek (TN)
Rilutek|||Rilutor|||6-(Trifluoromethoxy)-2-benzothiazolamine
rilutor
Riluzol
Riluzol [INN-Spanish]
riluzole
Riluzole (JAN/USAN/INN)
Riluzole (Rilutek)
Riluzole [USAN:INN]
Riluzole [USAN:USP:INN:BAN]
Riluzole HCl
Riluzole, 98% 5g
Riluzole, solid
Riluzole, United States Pharmacopeia (USP) Reference Standard
Riluzole(Rilutek)/
Riluzolum
Riluzolum [INN-Latin]
RP 54274
RP-54274
RP28111
RP54274
s1614
SBB012436
SBI-0051034.P002
SC-18839
SC-64630
SCHEMBL78905
SMR000058231
SPBio_000599
SPBio_001954
Spectrum2_000550
ST038494
ST068834
ST24029598
STK503686
Tocris-0768
Tox21_110252
Tox21_110252_1
Tox21_501064
TR-007739
UNII-7LJ087RS6F
VU0239571-11
Z166605314
ZB000641
ZERO/001785
ZINC6481

US Patents and Regulatory Information for RILUTEK

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Covis Pharma Bv RILUTEK riluzole TABLET;ORAL 020599-001 Dec 12, 1995 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
UBS
Accenture
Harvard Business School
QuintilesIMS
Chinese Patent Office
Mallinckrodt
Merck
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.